BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12769116)

  • 1. Senior prescription drug coverage: the state of the medigap markets in Massachusetts and New Hampshire.
    Miller M; Turnbull N
    Issue Brief (Mass Health Policy Forum); 2000; (7):1-34. PubMed ID: 12769116
    [No Abstract]   [Full Text] [Related]  

  • 2. The state of the medigap market in Massachusetts.
    Miller M; Turnbull N
    Issue Brief (Mass Health Policy Forum); 1998 Apr; (1):1-21. PubMed ID: 12769084
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
    Finkelstein A
    J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 6. The new Medicare drug benefit: much ado about little?
    Pauly MV
    LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drugs and the elderly: issues and options.
    Long SH
    Health Aff (Millwood); 1994 Spring (II); 13(2):157-74. PubMed ID: 8056369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Private, individual drug coverage in the current Medicare market.
    Boccuti C; Moon M
    Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug costs for Medicare beneficiaries: coverage and health status matter.
    Stuart B; Shea D; Briesacher B
    Issue Brief (Commonw Fund); 2000 Jan; (365):1-9. PubMed ID: 11584831
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicare prescription drugs: a benefit whose time has come.
    Benjamin GC
    Physician Exec; 1999; 25(4):89-90. PubMed ID: 10557496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.
    Laschober MA; Kitchman M; Neuman P; Strabic AA
    Health Aff (Millwood); 2002; Suppl Web Exclusives():W127-38. PubMed ID: 12703569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare supplemental insurance (Medigap).
    Stein N
    Issue Brief Cent Medicare Educ; 2003; 4(6):1-6. PubMed ID: 14503483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle.
    Andersen LS
    Issue Brief Cent Medicare Educ; 2005; 5(10):1-10. PubMed ID: 15943013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the influence of insurance effects on prescription drug coverage.
    McKercher PL; Taylor SD
    Ann Pharmacother; 2002 Nov; 36(11):1805-6. PubMed ID: 12432894
    [No Abstract]   [Full Text] [Related]  

  • 18. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
    Demchak C
    Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.